Grant Tarsus Pharmaceuticals, Inc. Transaction History
Grant
- $192 Million
- Q2 2024
A detailed history of Grant transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Grant holds 53,600 shares of TARS stock, worth $1.64 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
53,600
Previous 53,610
0.02%
Holding current value
$1.64 Million
Previous $1.95 Million
25.26%
% of portfolio
0.76%
Previous 1.02%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
155Shares Held
40.4MCall Options Held
37.9KPut Options Held
808K-
Rtw Investments, LP New York, NY3.41MShares$104 Million1.55% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$99.9 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$74.5 Million2.68% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$69 Million7.48% of portfolio
-
Cowen And Company, LLC2.2MShares$67.2 Million1.53% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $815M
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...